Topiramate in the treatment of severe myoclonic epilepsy in infancy
Authors:
- R CandauRCR Candau
- M Nieto-JimenezMNM Nieto-Jimenez
- A CorreaACA Correa
- L Ruiz del PortalLPL Ruiz del Portal
- 1 December 2000
- journal article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 9 (8) , 590-594
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A double-blind, randomized trial of topiramate in Lennox–Gastaut syndromeNeurology, 1999
- A Pilot Study of Topiramate in the Treatment of Infantile SpasmsEpilepsia, 1998
- Lamotrigine and Seizure Aggravation in Severe Myoclonic EpilepsyEpilepsia, 1998
- TopiramateSeminars in Pediatric Neurology, 1997
- New antiepileptic drugs: a systematic review of their efficacy and tolerabilityBMJ, 1996
- Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsyEpilepsy Research, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosagesNeurology, 1996
- Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds.Pharmacological Reviews, 1990
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989